Ignite Creation Date:
2025-12-24 @ 4:45 PM
Ignite Modification Date:
2025-12-28 @ 6:25 PM
Study NCT ID:
NCT04698850
Status:
WITHDRAWN
Last Update Posted:
2022-08-10
First Post:
2021-01-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Brolucizumab vs. Aflibercept for Retinal Angiomatous Proliferation
Sponsor:
Faculty Hospital Kralovske Vinohrady
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-04
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-05
First Submit QC Date:
None
Study First Post Date:
2021-01-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-07
Last Update Post Date:
2022-08-10
Last Update Post Date Type:
ACTUAL